Pseudomyxoma Peritonei: Role of 18F-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction

European Journal of Surgical Oncology

Volumn 36, Issue 3, 2010, Pages 315-323

  Passot, G ^a,b   Glehen, O ^a,b   Pellet, O ^a   Isaac, S ^a   Tychyj, C ^a   Mohamed, F ^c   Giammarile, F ^a   Gilly, F N ^a,b   Cotte, E ^a,b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ LYON 1   (France)

^c NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

Author keywords

18F FDG PET; Preoperative assessment; Prognosis; Pseudomyxoma peritonei

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; MITOMYCIN C;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LAPAROTOMY; MALE; PERITONEUM PSEUDOMYXOMA; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 76449107136     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.09.001     Document Type: Article

References (30)

1. Mann Jr. W.J., Wagner J., Chumas J., et al. The management of pseudomyxoma peritonei. Cancer 66 (1990) 1636-1640
2. Elias D., and Sabourin J.C. [Pseudomyxoma peritonei. A review]. J Chir (Paris) 136 (1999) 341-347
3. Ronnett B.M., Kurman R.J., Zahn C.M., et al. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol 26 (1995) 509-524
4. Ronnett B.M., Shmookler B.M., Diener-West M., et al. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol 16 (1997) 1-9
5. Sugarbaker P.H. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?. Lancet Oncol 7 (2006) 69-76
6. Ronnett B.M., Yan H., Kurman R.J., et al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 92 (2001) 85-91
7. Ronnett B.M., Zahn C.M., Kurman R.J., et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol 19 (1995) 1390-1408
8. Sugarbaker P.H., and Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6 (1999) 727-731
9. Glehen O., Kwiatkowski F., Sugarbaker P.H., et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22 (2004) 3284-3292
10. Jacquet P., and Sugarbaker P.H. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82 (1996) 359-374
11. Baratti D., Kusamura S., Nonaka D., et al. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 15 (2008) 526-534
12. Yan T.D., Black D., Savady R., and Sugarbaker P.H. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol 14 (2007) 484-492
13. Turlakow A., Yeung H.W., Salmon A.S., et al. Peritoneal carcinomatosis: role of (18)F-FDG PET. J Nucl Med 44 (2003) 1407-1412
14. Tanaka T., Kawai Y., Kanai M., et al. Usefulness of FDG-positron emission tomography in diagnosing peritoneal recurrence of colorectal cancer. Am J Surg 184 (2002) 433-436
15. Suzuki A., Kawano T., Takahashi N., et al. Value of 18F-FDG PET in the detection of peritoneal carcinomatosis. Eur J Nucl Med Mol Imaging 31 (2004) 1413-1420
16. Gilly F.N., Carry P.Y., Sayag A.C., et al. Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 41 (1994) 124-129
17. Gilly F.N., Cotte E., Brigand C., et al. Quantitative prognostic indices in peritoneal carcinomatosis. Eur J Surg Oncol 32 (2006) 597-601
18. Sugarbaker P.H. Peritonectomy procedures. Ann Surg 221 (1995) 29-42
19. Sugarbaker P.H. Are there curative options to peritoneal carcinomatosis?. Ann Surg 242 (2005) 748-750 author reply 50-51
20. Zissin R., Gayer G., Kots E., et al. Imaging of mucocoele of the appendix with emphasis on the CT findings: a report of 10 cases. Clin Radiol 54 (1999) 826-832
21. Sulkin T.V., O'Neill H., Amin A.I., and Moran B. CT in pseudomyxoma peritonei: a review of 17 cases. Clin Radiol 57 (2002) 608-613
22. Sugarbaker P.H., Ronnett B.M., Archer A., et al. Pseudomyxoma peritonei syndrome. Adv Surg 30 (1996) 233-280
23. Bechtold R.E., Chen M.Y., Loggie B.W., et al. CT appearance of disseminated peritoneal adenomucinosis. Abdom Imaging 26 (2001) 406-410
24. Jacquet P., Jelinek J.S., Steves M.A., et al. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 72 (1993) 1631-1636
25. Lim J.S., Kim M.J., Yun M.J., et al. Comparison of CT and 18F-FDG pet for detecting peritoneal metastasis on the preoperative evaluation for gastric carcinoma. Korean J Radiol 7 (2006) 249-256
26. Dromain C., Leboulleux S., Auperin A., et al. Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT. Abdom Imaging 33 (2008) 87-93
27. Yang Q.M., Bando E., Kawamura T., et al. The diagnostic value of PET-CT for peritoneal dissemination of abdominal malignancies. Gan To Kagaku Ryoho 33 (2006) 1817-1821
28. Glehen O., Osinsky D., Cotte E., et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 10 (2003) 863-869
29. Kusamura S., Baratti D., Antonucci A., et al. Incidence of postoperative pancreatic fistula and hyperamylasemia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 14 (2007) 3443-3452
30. Stephens A.D., Alderman R., Chang D., et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 6 (1999) 790-796